Home
Drugs
Yervoy
Clinical Trials

Clinical Trials Related to Yervoy

Related studies linked through entity extraction aliases.

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

Status: RECRUITING
Phase: PHASE1

Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma

Status: COMPLETED
Phase: PHASE1

An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma

Status: COMPLETED
Phase: PHASE2

Yervoy Pregnancy Surveillance Study

Status: WITHDRAWN
Phase: N/A

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Status: COMPLETED
Phase: PHASE1